Find similar products:
The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 39307/0027.
Clobazam Thame 5mg/5ml and 10mg/5ml Oral Suspension
Clobazam Thame 5mg/5ml Oral Suspension
Clobazam Thame 10mg/5ml Oral Suspension
clobazam
The name of your medicine is Clobazam Thame 5mg/5ml or 10mg/5ml Oral Suspension but will be referred to as Clobazam throughout this leaflet.
1. What Clobazam is and what it is used for
2. What you need to know before you take Clobazam
3. How to take Clobazam
4. Possible side effects
5. How to store Clobazam
6. Contents of the pack and other information
This medicine contains the active substance clobazam which belongs to a group of medicines called benzodiazepines. It works by having a calming effect on the brain.
Do not take if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking Clobazam.
Note: Make sure that you receive the same clobazam medicine every time you collect your prescription unless your doctor has agreed to change to a different clobazam medicine. If the appearance of this medicine is not the same as usual or if the dosage instructions have changed, speak to your doctor or pharmacist as soon as possible to make sure you have the right medicine.
Talk to your doctor or pharmacist before taking Clobazam if:
If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking Clobazam.
Suicidal thoughts
Tell your doctor straight away if you start thinking about suicide or harming yourself. Some patients have had suicidal thoughts while taking medicines containing clobazam, especially if they were also depressed.
Psychotic or ‘Paradoxical’ reactions
It is known that with the use of clobazam restlessness, agitation, irritability, aggression, delusions, rage, nightmares, hallucinations, deceptive thoughts (psychosis), inappropriate behaviour and other adverse behavioural effects may occur. If this happens you should stop taking Clobazam and contact your doctor. These reactions are more common in children and elderly patients.
Dependence, withdrawal and tolerance
You may become dependent on Clobazam if you take it for a long period of time or with high dose, particularly if you have a history of heavy alcohol or drug use. This means that you may feel that you need to continue treatment with Clobazam in order to feel well (known as psychological dependence). You should therefore take Clobazam for as short time as possible.
If you suddenly stop taking Clobazam you may experience worsening of the symptoms you were originally being treated for, as well as mood changes, anxiety, sleep disturbance, headache, increased dreaming, tension, confusion, excitability, hallucinations, muscle pain, numbness of the limb, tingling, sweating, tremor, nausea, sensitivity to light, increased sensitivity to sound, sensitivity to light or restlessness.
This is known as withdrawal symptoms and can be avoided by slowly reducing your dose. If you are worried about dependence or withdrawal please talk to your doctor.
If you take Clobazam for a long period of time for treatment of epilepsy it is possible that you may become tolerant to it, meaning that it will not be as effective as it was when you first started taking it. If you feel that Clobazam is no longer helping to control your symptoms please talk to your doctor, they may suggest you take a short break from this medicine.
Breathing difficulties
Clobazam may cause respiratory depression, particularly when administered at high doses. Tell your doctor if you have respiratory failure, your doctor will decide whether to reduce the dose. In case of severe respiratory disturbance, clobazam may not be used.
Serious skin problems
Clobazam may cause serious skin reactions. You should talk to your doctor if you develop any rash unless it is clearly not drug related.
Children
Clobazam should only be used in children from 1 month to 2 years old, under exceptional situations, where there is a clear epilepsy indication.
Please tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines. This includes medicines you buy without a prescription, including herbal medicines. This is because Clobazam can affect the way some other medicines work. Also, some medicines can affect the way Clobazam works.
In particular, tell your doctor if you are taking any of the following:
Concomitant use of Clobazam and opioids (strong pain killers, medicines for substitution therapy and some cough medicines) increases the risk of drowsiness, difficulties in breathing (respiratory depression), coma and may be life-threatening. Because of this, concomitant use should only be considered when other treatment options are not possible.
However, if your doctor does prescribe Clobazam together with opioids the dose and duration of concomitant treatment should be limited by your doctor.
Please tell your doctor about all opioid medicines you are taking, and follow your doctor’s dose recommendation closely. It could be helpful to inform friends or relatives to be aware of the signs and symptoms stated above. Contact your doctor when experiencing such symptoms.
If you are not sure if any of the above apply to you talk to your doctor or pharmacist.
If you are going to have an anaesthetic, tell your doctor or anaesthetist that you are taking Clobazam. This is because your doctor may need to change the amount of anaesthetic or muscle relaxants to give you.
Do not drink alcohol while taking Clobazam. This is because there is an increased risk of sleepiness and other side effects.
Pregnancy
Use of this medicine is not recommended during pregnancy and in women of childbearing potential not using contraception.
If you discover that you are pregnant or are planning to have a baby, consult your doctor right away to re-assess the need for treatment. Do not stop taking Clobazam without talking to your doctor.
A large amount of data has not shown evidence of malformations associated with the use of benzodiazepines. However, some studies have shown a potentially increased risk of cleft lip and palate in newborn babies compared to that in the general population.
Cleft lip and palate (sometimes called “harelip”) is a deformation at birth caused by incomplete fusion of the palate and upper lip.
Reduced fetal movement and fetal heart rate variability may occur after taking Clobazam during the second and/or third trimester of pregnancy.
If Clobazam is taken at the end of pregnancy or during childbirth, your baby may show drowsiness (sedation), muscle weakness (hypotonia or floppy infant syndrome), a drop in body temperature (hypothermia), difficulty feeding (problems suckling causing poor weight gain) and breathing problems (respiratory depression sometimes severe).
If taken regularly in late pregnancy, your baby may get withdrawal symptoms such as agitation or shaking. In this case the newborn should be closely monitored during the postnatal period.
Clobazam has major influence on the ability to drive and use machines. You may feel sleepy or have concentration or memory problems after taking this medicine. You may also experience double vision or you may react more slowly to things. If this happens, do not drive or use any tools or machines.
Talk to your doctor or pharmacist if you are not sure whether it is safe for you to drive while taking this medicine.
This medicine contains methyl parahydroxybenzoate (E218), which may cause allergic reactions (possibly delayed).
This medicine contains less than 1mmol sodium (23mg) per 5ml, that is to say essentially ‘sodium-free’.
Always take this medicine exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.
5mg/5ml Doses:
Adults (Anxiety and Epilepsy)
Children (over 2 years) (Epilepsy)
Elderly (Anxiety and Epilepsy)
10mg/5ml Doses:
Adults (Anxiety and Epilepsy)
Children (over 2 years) (Epilepsy)
Elderly (Anxiety and Epilepsy)
In patients with liver or kidney disease lower initial doses are required, with a gradual increase under careful observation of your doctor (see section “Warnings and precautions”).
1. Open the bottle: press the cap down and turn it anticlockwise.
2. Separate the adaptor from the syringe. Insert the adaptor into the bottle neck. Ensure it is fixed well. Take the syringe and put it in the adaptor opening. Turn the bottle upside down.
3. Fill the syringe with a small amount of suspension by pulling the piston down, then push the piston up in order to remove any possible air bubbles. Pull the piston down to the graduation mark corresponding to the quantity in millilitres (ml) prescribed by your doctor.
4. Turn the bottle the right way up. Remove the syringe from the adaptor.
5. Put the end of the syringe into the mouth and push the plunger slowly back in to deliver the medicine into the mouth.
6. Close the bottle with the plastic screw cap. Wash the syringe with water and store in a clean place.
If you take more Clobazam than you should, tell your doctor or go to your nearest hospital casualty department straight away. Do not drive yourself, because you may start to feel sleepy. Remember to take the medicine pack with you. This is so that the doctor knows what you have taken.
Keep taking this medicine until your doctor tells you to stop. Do not stop taking Clobazam just because you feel better.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. You may feel ill after taking this medicine, or notice unusual or unexpected symptoms. If this happens, tell your doctor.
Tell your doctor straight away if you get any of the side effects listed above. Your doctor may decide that your treatment needs to be stopped.
Tell your doctor or pharmacist if any of the following side effects get serious or lasts longer than a few days.
The following side effects are more likely to happen at the start of treatment. They usually last for a short time:
If you take this medicine for a long time, you are more likely to get the following side effects:
If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
The active substance is clobazam.
For 5mg/5ml: Each 5ml of oral suspension contains 5mg clobazam.
For 10mg/5ml: Each 5ml of oral suspension contains 10mg clobazam.
The other ingredients are methyl parahydroxybenzoate (E218), citric acid monohydrate (E330), sodium citrate (E331), sucralose (E955), xanthan gum (E415) and purified water.
Clobazam is white to off-white viscous liquid supplied in an amber glass bottle with tamper-evident child resistant plastic screw cap and a 5ml polypropylene oral syringe with 0.1ml graduation mark and an adaptor for the syringe. Where higher doses are to be administered, dosing cups should be considered.
Clobazam is supplied in bottles containing 100ml and 150ml suspension.
Not all pack sizes may be marketed.
POM
If this leaflet is hard to see or read, please call +44 (0) 208 515 3700 for help.
This leaflet was last revised in 07/2023.
31043204.05